|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-18
|
$272,648
|
$136,324
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
$104,006
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
$0
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Dissecting sarcoma complexity via innovative microRNA and informatics approaches
|
5K22CA138716-02
|
$191,160
|
$191,160
|
Spentzos, Dimitrios
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Multifunctional Peptides for (MRI) Imaging
|
1R43CA159771-01
|
$186,994
|
$93,497
|
Beattie, Craig
|
CDG THERAPEUTICS, INC.
|
|
Autophagy and apoptosis in the response of c-KIT cancers to targeted therapy
|
1K08CA154782-01A1
|
$143,362
|
$71,681
|
GORDON, PETER
|
CHILDREN'S HOSPITAL BOSTON
|
|
Metabolic roles for Lin28-let-7 miRNA pathway in sarcoma tumorigenesis
|
1K08CA157727-01
|
$174,410
|
$174,410
|
ZHU, HAO
|
CHILDREN'S HOSPITAL BOSTON
|
|
Cancer Biology in the Zebrafish
|
5R01CA103846-09
|
$364,298
|
$182,149
|
ZON, LEONARD
|
CHILDREN'S HOSPITAL BOSTON
|
|
GLI1 and Cancer Stem Cells in Ewing Sarcoma
|
5R21CA137485-02
|
$168,781
|
$168,781
|
MAY, WILLIAM
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-20
|
$258,854
|
$85,422
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Third International Chordoma Research Workshop: Catalyzing New Advances in Chordo
|
3R13CA153794-01S1
|
|
$0
|
Les, Edward
|
CHORDOMA FOUNDATION
|
|
Cancer Center Support Grant
|
3P30CA033572-28S1
|
$91,911
|
$919
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S2
|
$75,000
|
$750
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S3
|
$139,999
|
$1,400
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-28
|
$2,225,352
|
$22,254
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibitors in Src Signaling for Antitumor Therapy
|
5R01CA115674-05
|
$280,320
|
$140,160
|
Jove, Richard
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-10
|
$227,795
|
$227,795
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Walleye Dermal Sarcooma Virus Accessory Protein Function
|
4R01CA095056-08
|
$229,962
|
$229,962
|
QUACKENBUSH, SANDRA
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
|
Chemical genetic profiling of engineered tumor cells
|
3R01CA097061-09S1
|
$61,770
|
$61,770
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Chemical genetic profiling of engineered tumor cells
|
5R01CA097061-09
|
$353,067
|
$353,067
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
The role of DKK1, a Wnt-Inhibitor, in Mesenchymal Differentiation/Sarcomagenesis
|
5K08CA132986-03
|
$169,884
|
$169,884
|
MATUSHANSKY, IGOR
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
|
1U01CA140207-01A2
|
$656,025
|
$328,013
|
SCHWARTZ, LAWRENCE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S5
|
$11,164,583
|
$111,646
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-46S6
|
$75,000
|
$750
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Exploiting mouse models of pediatric cancers and epigenetics for therapy
|
5U01CA105423-08
|
$807,035
|
$266,322
|
ORKIN, STUART
|
DANA-FARBER CANCER INSTITUTE
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S1
|
$37,988
|
$1,140
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-37
|
$5,723,821
|
$171,715
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
Dissecting Mechanisms of Metastasis Through Comparative Systems Genetics
|
5R01CA138265-04
|
$444,268
|
$444,268
|
KIRSCH, DAVID
|
DUKE UNIVERSITY
|
|
Molecular Modeling of Pediatric Skeletal Muscle Tumors
|
5R01CA122706-03
|
$282,590
|
$282,590
|
LINARDIC, CORINNE
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-37S2
|
$75,000
|
$2,250
|
MEANS, ANTHONY
|
DUKE UNIVERSITY
|
|
The ARF Tumor Suppressor
|
5R01CA139319-02
|
$351,225
|
$87,806
|
MURPHY, MAUREEN
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
2P30CA006927-48
|
$4,038,908
|
$121,167
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S1
|
$50,859
|
$1,526
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S2
|
$74,930
|
$2,248
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S3
|
$140,001
|
$4,200
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-48S4
|
$300,000
|
$9,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Preliminary Evaluation of FDG-PET with anti-IGF-1R Targeted Therapy in GISTs
|
1R21CA150381-01A1
|
$273,938
|
$273,938
|
von Mehren, Margaret
|
FOX CHASE CANCER CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S1
|
$116,988
|
$1,170
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S2
|
$704,000
|
$7,040
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S3
|
$211,800
|
$2,118
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S4
|
$75,000
|
$750
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-37S5
|
$139,269
|
$1,393
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-37
|
$10,429,029
|
$104,290
|
Corey, Lawrence
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting EWS/FLI1-driven pathways to improve therapeutic gains in Ewing's Sarcom
|
5R01CA134727-04
|
$308,958
|
$308,958
|
NOTARIO, VICENTE
|
GEORGETOWN UNIVERSITY
|
|
Novel Compounds to Inactivate Oncogenic Fusion Proteins
|
5R01CA133662-03
|
$308,958
|
$308,958
|
TORETSKY, JEFFREY
|
GEORGETOWN UNIVERSITY
|
|
Isolation and small molecule targeting of Ewing's Sarcoma stem cells
|
5R01CA138212-04
|
$461,919
|
$461,919
|
TORETSKY, JEFFREY
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
3P30CA051008-18S2
|
$169,999
|
$13,600
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Georgetown University, Lombardi Cancer Center Support Grant Competitive Renewal
|
5P30CA051008-18
|
$1,550,495
|
$124,040
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
Regulation and Function of Mammalian HSF4 in vivo
|
5R01CA132640-11
|
$257,626
|
$128,813
|
MIVECHI, NAHID
|
GEORGIA HEALTH SCIENCES UNIV RES INSTIT
|
|
Interplay between 14-3-3gamma and MDMX in regulating the p53 pathway
|
5R01CA127724-05
|
$275,221
|
$68,805
|
Lu, Hua
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Total relevant funding to Sarcoma for this search: $45,273,566
|